The University of Kansas School of Pharmacy’s Doctor of Pharmacy program has been placed on “accredited with probation” status by the Accreditation Council for Pharmacy Education after the accreditor identified deficiencies in experiential learning, student services, faculty staffing, governance and resources.
The ACPE board found the program non-compliant with standards for organization and governance, experiential learning, and students and student services, and faculty and staff. The board’s June report cited inadequate staffing in the Office of Experiential Education, insufficient staffing for recruiting and admissions, and inadequate faculty strength in the Department of Pharmacy Practice to support the curriculum. It found the program non-compliant with organization and governance because of communication and transparency issues and failure to follow meeting requirements in the school’s Faculty Policies and Procedures Manual. The board rated the school’s resources as partially compliant because of insufficient and untimely disclosure of financial adequacy for the Pharm.D. program.
ACPE scheduled a focused evaluation for spring 2027 and invited KU School of Pharmacy representatives to appear before the board at its January 2027 meeting.
The school’s website states its Pharm.D. program is accredited through June 30, 2030, and that graduates remain eligible to take the North American Pharmacist Licensure Examination and the Multistate Pharmacy Jurisprudence Examination.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.